Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Foundation Models on Wearable EEG using Self-Supervised LearningJiansheng Niu, Aravind Ravi, Nicolas Florez Torres, et al.Internal Medicine Journal|August 8, 2017
Risk stratification in the investigation of pulmonary nodules in a high-risk cohort: positron emission tomography/computed tomography outperforms clinical risk prediction algorithmsGlenna Gibson, Aravind Ravi Kumar, Karin Steinke, et al.Journal of Biomechanical Engineering|March 8, 2024
Hybrid Soft-Rigid Active Prosthetics Laboratory Exercise for Hands-On Biomechanical and Biomedical Engineering EducationRun Ze Gao, Peter S Lee, Aravind Ravi, et al.Respirology (Carlton, Vic.)|June 27, 2015
Grey scale texture analysis of endobronchial ultrasound mini probe images for prediction of benign or malignant aetiologyPhan Nguyen, Farzad Bashirzadeh, Justin Hundloe, et al.Chest|September 3, 2011
Optical differentiation between malignant and benign lymphadenopathy by grey scale texture analysis of endobronchial ultrasound convex probe imagesPhan Nguyen, Farzad Bashirzadeh, Justin Hundloe, et al.Thyroid : Official Journal of the American Thyroid Association|October 23, 2019
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving ProtocolAmir Iravani, Benjamin Solomon, David A Pattison, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 2019
The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and ParagangliomaGrace Kong, Tess Schenberg, Christopher J Yates, et al.European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2018
Dosimetry of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment OutcomesJohn Violet, Price Jackson, Justin Ferdinandus, et al.The Lancet. Oncology|May 13, 2018
[<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyMichael S Hofman, John Violet, Rodney J Hicks, et al.Pageof 3